You are using software which is blocking our advertisements (adblocker).

As we provide the news for free, we are relying on revenues from our banners. So please disable your adblocker and reload the page to continue using this site.
Thanks!

Click here for a guide on disabling your adblocker.

App icon
FreshPublishers
Open in the app
OPEN

CSQ invites public comments on EU GMP Addendum

CSQ has published its new EU GMP Addendum, initiating the official public comment period for industry stakeholders to weigh in on the program and audit requirements. CSQ's addendum is meant to help producers of cannabinoid materials and products across the globe verify that their product meets EudraLex Volume 4, Parts 1 & 2, and Annex 7 (EU-GMP) regulatory requirements for medicinal herbal products.

The EU GMP Addendum is not a standalone regulatory certification. Instead, its a third party validation of a producer's existing certification issued by a "Competent Authority," proving the producer's compliance with EU-GMP regulatory requirements for potential buyers.

From the producer's perspective, the CSQ EU-GMP Addendum is an additional third party verification that provides a paper trail of compliance, proving that the producer is not greenwashing the supply chain. The term "greenwashing" in this case refers to a deceptive practice where products are imported and then falsely labeled as being EU GMP certified before being sold across Europe.

"It's crucial for operators, regulators, and suppliers across the globe to weigh in on this, because the greenwashing must come to an end. When a pharmacist in Europe sells a medical cannabinoid product to a patient, they shouldn't have to question whether or not that product is safe, or if GMPs were followed, they should know without a doubt. That's what our EU GMP Addendum is meant to do," said Darwin Millard, Technical Director of CSQ.

The CSQ Certification Program is based on ASTM, ISO, cGMP/cGACP, HACCP, and other internationally recognized standards and best practices. The program provides a roadmap for organizations to continuously improve their processes and achieve a best-in-class Cannabis Safety & Quality Management System.

Stakeholders, regulators, and other industry experts are encouraged to provide feedback from now until June 1st by downloading the CSQ 2.0 EU GMP Addendum document and submitting responses through the Public Comment Form available online at the link here.

For more information:
Cannabis Safety & Quality
[email protected]
csqcertification.com

Related Articles → See More